Aptevo Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Aptevo Therapeutics

09/05/2024 14:32

* Aptevo Therapeutics Inc  APVO.OQ  reported a quarterly
adjusted
loss of $9.95​​ per share for the quarter ended in March, lower
than the same quarter last year, when the company reported EPS
of $17.16.  The mean expectation of two analysts for the quarter
was for a loss of $12.84 per share. Wall Street expected
results to range from $-14.10 to $-11.59 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aptevo Therapeutics Inc's reported EPS for the quarter was
a
loss of $9.95​.
    * The company reported a quarterly loss of $6.83 million.
    * Aptevo Therapeutics Inc shares had fallen by 78.1% this
quarter and lost 87.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 18.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $13.75 
This summary was machine generated from LSEG data May 9 at 01:31
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -12.84         -9.95          Beat
 Dec. 31 2023      -18.04         -6.16          Beat
 Sep. 30 2023      -33.00         -22.00         Beat
 Jun. 30 2023      -49.28         -54.12         Missed